Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 2:26 AM ET

Capital Markets

Company Overview of International Biotechnology Trust plc

Company Overview

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund’s assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of ...

25 Southampton Buildings

London,  WC2A 1AL

United Kingdom

Founded in 1994


44 20 7421 7070


44 20 7421 7077

Key Executives for International Biotechnology Trust plc

Managing Partner
IBT Investment Manager
Finance Partner of Europe
Compensation as of Fiscal Year 2015.

International Biotechnology Trust plc Key Developments

David Clough to Retire as Non-Executive Director of International Biotechnology Trust plc

International Biotechnology Trust plc announced that Dr. David Clough will retire as a non-executive Director of the company, with effect from 9 December 2015.

International Biotechnology Trust plc, Annual General Meeting, Dec 09, 2015

International Biotechnology Trust plc, Annual General Meeting, Dec 09, 2015., at 12:30 GMT Standard Time. Location: BNP Paribas Fortis. Agenda: To receive the directors' report and the audited financial statements for the year ended 31 August 2015; to approve the annual report on directors' remuneration for the year ended 31 August 2015; to re-elect Alan Clifton and Véronique Bouchet as director of the company; to elect Mrs. Caroline Gulliver as a director of the company; to re-appoint PricewaterhouseCoopers LLP as the Independent Auditors; to consider the company continue as an investment trust for a further two year; to authorise to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the company; to consider the board be given power to allot equity securities; and to consider General Meeting (other than an AGM) may be called on not less than 14 clear days' notice.

International Biotechnology Trust plc Announces Audited Group Earnings Results for the Year Ended August 31, 2015

International Biotechnology Trust plc announced audited group earnings results for the year ended August 31, 2015. For the year, the company reported profit before finance costs and tax of £78,699,000 compared to £44,863,000 a year ago. Profit on ordinary activities before tax was £78,533,000 compared to £44,754,000 a year ago. Profit for the year attributable to owners of the parent company was £78,479,000 or 178.54 pence per basic and diluted share compared to £44,719,000 or 81.30 pence per basic and diluted share a year ago. Net cash flows generated from operating activities were £38,897,000 compared to net cash flows used in operating activities of £2,231,000 a year ago.

Similar Private Companies By Industry

Company Name Region
American Equities Overseas (UK) Ltd. Europe
Hesperia Management Europe
Kinabalu Financial Products LLP Europe
Codelco Services Ltd. Europe
WH Ireland (Financial Services) Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact International Biotechnology Trust plc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at